Streetbeat News

Stock Prices

BBIO

BridgeBio Pharma has appointed Thomas Trimarchi as President and Chief Operating Officer, effective immediately.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 11:35 am

HCA

HCA Healthcare has raised its FY24 EPS guidance to $21.60-$22.80, up from the previous range of $19.70-$21.20, surpassing the consensus estimate of $20.98.

Portfolio Pulse from Bill Haddad

July 23, 2024 | 11:34 am

WBS

Webster Financial (NYSE: WBS) reported Q2 earnings of $1.26 per share, missing the analyst estimate of $1.34. Sales were $572.30M, also below the $589.41M estimate. Both earnings and sales decreased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 11:34 am

HCA

HCA Healthcare has revised its FY24 revenue forecast to a range of $69.75 billion to $71.75 billion, up from the previous range of $67.75 billion to $70.25 billion.

Portfolio Pulse from Bill Haddad

July 23, 2024 | 11:34 am

DIS

NFLX

WBD

Netflix's Q2 results show strong growth in advertising and global subscribers, with revenue and earnings surpassing estimates. The company gained 8.05 million net paid customers, reaching nearly 278 million subscribers. Netflix's Q3 revenue guidance is below Wall Street's estimates, but it increased its full-year revenue guidance. The company is focusing on monetizing its ad inventory and using AI to enhance content discovery.

Portfolio Pulse from Upwallstreet

July 23, 2024 | 11:33 am

BRK

BYDDY

TSM

Berkshire Hathaway has reduced its stake in BYD Company to below 5%, indicating a shift in focus towards U.S. investments. This move follows a gradual reduction in BYD holdings since August 2022. Berkshire also sold its entire stake in Taiwan Semiconductor Manufacturing Company earlier this year.

Portfolio Pulse from Shivani Kumaresan

July 23, 2024 | 11:32 am

HCA

HCA Healthcare shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 11:32 am

LMT

Lockheed Martin has provided its financial outlook for FY24, projecting net sales between $70.5 billion and $71.5 billion, which is below the estimated $72.4 billion. The company also expects diluted EPS to be in the range of $26.10 to $26.60, falling short of the $27.96 estimate.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 11:31 am

ACRS

BOF

CRWE

IVFH

Insiders are buying shares of Aclaris Therapeutics, BranchOut Food, Innovative Food Holdings, and Crown Equity Holdings, indicating confidence in these companies. Notable transactions include significant purchases by directors and officers.

Portfolio Pulse from Avi Kapoor

July 23, 2024 | 11:31 am

HCA

HCA Healthcare reported Q2 2024 adjusted EPS of $5.50, beating the $4.88 estimate, and sales of $17.492 billion, surpassing the $17.046 billion estimate. This represents a 10.28% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 11:31 am